Driving Growth Rising Incidence Of Infectious Diseases In Hematology Analyzers And Reagents: The Driving Engine Behind Hematology Analyzers and Reagents Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Hematology Analyzers and Reagents Market Size Growth Forecast: What to Expect by 2025?
The market size for hematology analyzers and reagents has seen considerable growth in the past few years. The market is expected to surge from $4.9 billion in 2024 to $5.25 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.1%. The spurt in growth during the historical stretch is largely due to the escalating prevalence of chronic illnesses, an aging demographic, heightened disease burden, and an increasing incidence of infectious diseases.

How Will the Hematology Analyzers and Reagents Market Size Evolve and Grow by 2029?
The market for hematology analyzers and reagents is predicted to witness robust growth in the coming years, with its size reaching $6.63 billion by 2029 at a 6.0% Compound Annual Growth Rate (CAGR). The forecasted growth could be due to international health issues, increased investments in infrastructure related to hematology analyzers and reagents, customised medical treatments, and the rise of remote monitoring. Key trends anticipated in this period encompass technological breakthroughs, heightened sensitivity in testing, molecular hematology examinations, automation and integration, Point-Of-Care Testing (POCT), application of data analytics and artificial intelligence, as well as digital hematology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

What Drivers Are Propelling the Growth of Hematology Analyzers and Reagents Market Forward?
The hematology analyzers and reagents market is projected to grow due to the increasing prevalence of infectious diseases. Such diseases, caused by pathogenic microorganisms like bacteria, viruses, fungi, or parasites, can be transmitted between individuals or through environmental exposure. Various interconnected factors contribute to this surge, including globalization that eases pathogen transmission, antibiotic overuse leading to antimicrobial resistance, and specific socioeconomic conditions. Hematology analyzers provide crucial data for epidemiological studies, helping public health officials monitor outbreaks and understand infectious disease propagation mechanisms. To illustrate, the Centers for Disease Control and Prevention, a US government agency, reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, indicating a rise of 1,295 cases. Consequently, the growing prevalence of infectious diseases is fuelling the advancement of the hematology analyzer and reagent market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2572&type=smp

Which Emerging Trends Are Transforming the Hematology Analyzers and Reagents Market in 2025?
The hematology analyzers and reagents market is being hampered by the recalls of defective hematology analyzers. These recalls are initiated by the product's manufacturer or developer when defects or safety issues are uncovered that could threaten the consumer. A defective hematology analyzer can produce incorrect findings and potentially lead to a misdiagnosis, which jeopardizes the public's trust in these analyzers. Regulatory bodies are warning healthcare experts to recognize the potential for inaccurate diagnoses with these analyzers and take necessary measures such as the use of alternate diagnostic tests or validation of analyzer results through manual scanning or estimation of cell counts. For example, Beckman Coulter Life Sciences recalled its DxH800, DxH600, and DxH900 hematology analyzers due to the risk of unreliable results. These product recalls can not only impose a considerable safety threat to the public but also inflict substantial financial and reputational harm to the involved companies.

What Are the Key Segments in the Hematology Analyzers and Reagents Market?
The hematology analyzers and reagents market covered in this report is segmented -

1) By Product: Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Slide Stainers, Differential Counters, Hematology Stains
2) By Applications: Anemias, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Other Applications
3) By End User: Specialized Research Institutes, Hospitals, Specialized Diagnostic Centers, Other End Users

Subsegments:
1) By Hematology Analyzers: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers
2) By Hemostasis Analyzers: Platelet Function Analyzers, Coagulation Testing Analyzers
3) By Plasma Protein Analyzers: Electrophoresis Analyzers, Immunofixation Analyzers
4) By Hemoglobin Analyzers: Point-Of-Care Hemoglobin Analyzers, Laboratory Hemoglobin Analyzers
5) By Erythrocyte Sedimentation Rate Analyzer: Manual ESR Analyzers, Automated ESR Analyzers
6) By Coagulation Analyzer: Clotting Time Analyzers, Thromboelastography (TEG) Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2572&type=smp

Who Are the Key Players Shaping the Hematology Analyzers and Reagents Market's Competitive Landscape?
Major companies operating in the hematology analyzers and reagents market include Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS

What Geographic Markets Are Powering Growth in the Hematology Analyzers and Reagents Market?
The countries covered in the hematology analyzers and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2572

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.